Cargando…

Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition

Human enteroviruses are responsible for diverse diseases, from mild respiratory symptoms to fatal neurological complications. Currently, no registered antivirals have been approved for clinical therapy. Thus, a therapeutic agent for the enterovirus-related disease is urgently needed. Remdesivir (GS-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Wei, Yao, Min, Dong, Yangchao, Ye, Chuantao, Wang, Dan, Liu, He, Ma, Hongwei, Zhang, Hui, Qi, Libin, Yang, Yuewu, Wang, Yuan, Zhang, Liang, Cheng, Linfeng, Lv, Xin, Xu, Zhikai, Lei, Yingfeng, Zhang, Fanglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304253/ https://www.ncbi.nlm.nih.gov/pubmed/32595613 http://dx.doi.org/10.3389/fmicb.2020.01105

Ejemplares similares

Corrigendum: Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition
por: Ye, Wei, et al.
Publicado: (2020)

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
por: Amirian, E. Susan, et al.
Publicado: (2020)

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Agostini, Maria L., et al.
Publicado: (2018)

Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections
por: Saqrane, S., et al.
Publicado: (2021)

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
por: de Wit, Emmie, et al.
Publicado: (2020)

Phosphoramidate Prodrugs Continue to Deliver, The Journey of Remdesivir (GS-5734) from RSV to SARS-CoV-2
por: Mackman, Richard L.
Publicado: (2022)

Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
por: Ye, Chuantao, et al.
Publicado: (2020)

An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
por: Ye, Chuantao, et al.
Publicado: (2019)

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
por: Lo, Michael K., et al.
Publicado: (2017)

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
por: Warren, Travis K., et al.
Publicado: (2016)

Isolation of Endogenously Assembled RNA-Protein Complexes Using Affinity Purification Based on Streptavidin Aptamer S1
por: Dong, Yangchao, et al.
Publicado: (2015)

Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor
por: Wang, Bin, et al.
Publicado: (2022)

Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of I (K(M)) or I (K(DR)) and in the Stimulation of I (MEP)
por: Chang, Wei-Ting, et al.
Publicado: (2020)

The structure of Crimean-Congo hemorrhagic fever virus Gc is revealed; many more still need an answer
por: Ye, Wei, et al.
Publicado: (2022)

Broad-spectrum Investigational Agent GS-5734 for the Treatment of Ebola, MERS Coronavirus and Other Pathogenic Viral Infections with High Outbreak Potential
por: Jordan, Robert, et al.
Publicado: (2017)

Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry
por: Xu, Fengwen, et al.
Publicado: (2016)

Lessons from Pasteur may help prevent the deadly relapse of Ebola in patients: Using contingency vaccination to avoid Ebola relapse in immune-privileged organs
por: Ye, Wei, et al.
Publicado: (2023)

An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo
por: Zhao, Yajing, et al.
Publicado: (2022)

The Long Noncoding RNA NEAT1 Exerts Antihantaviral Effects by Acting as Positive Feedback for RIG-I Signaling
por: Ma, Hongwei, et al.
Publicado: (2017)

Practical and Highly Efficient Synthesis of Remdesivir from GS-441524
por: Hu, Tianwen, et al.
Publicado: (2022)

RIPK3 Promotes JEV Replication in Neurons via Downregulation of IFI44L
por: Bian, Peiyu, et al.
Publicado: (2020)

Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats
por: Yang, Ling, et al.
Publicado: (2022)

An efficient synthesis of RNA containing GS-441524: the nucleoside precursor of remdesivir
por: Moorthy, Ramkumar, et al.
Publicado: (2021)

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
por: Leegwater, E., et al.
Publicado: (2022)

Transplacental transfer of Remdesivir and GS‐441524: An ex vivo perfusion study
por: Louchet, Margaux, et al.
Publicado: (2023)

RIPK3 promotes hantaviral replication by restricting JAK-STAT signaling without triggering necroptosis
por: Si, Yue, et al.
Publicado: (2023)

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
por: Yan, Victoria C., et al.
Publicado: (2020)

Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality
por: Bian, Peiyu, et al.
Publicado: (2017)

Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
por: Cox, Robert M., et al.
Publicado: (2021)

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
por: Chiba, Shiho, et al.
Publicado: (2022)

Enterovirus Replication Organelles and Inhibitors of Their Formation
por: Li, Xinhong, et al.
Publicado: (2020)

Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
por: Xie, Jiashu, et al.
Publicado: (2021)

MLKL Mediated Necroptosis Accelerates JEV-Induced Neuroinflammation in Mice
por: Bian, Peiyu, et al.
Publicado: (2017)

Induction of Specific Humoral and Cellular Immune Responses in a Mouse Model following Gene Fusion of HSP70C and Hantaan Virus Gn and S0.7 in an Adenoviral Vector
por: Cheng, Linfeng, et al.
Publicado: (2014)

COPI Is Required for Enterovirus 71 Replication
por: Wang, Jianmin, et al.
Publicado: (2012)

Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19
por: Lê, Minh Patrick, et al.
Publicado: (2020)

Interpatient variability in the pharmacokinetics of remdesivir and its main metabolite GS-441524 in treated COVID-19 subjects
por: Tempestilli, Massimo, et al.
Publicado: (2022)

Rheum emodin inhibits enterovirus 71 viral replication and affects the host cell cycle environment
por: Zhong, Ting, et al.
Publicado: (2017)

The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
por: Zhu, JiaYi, et al.
Publicado: (2022)

Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle
por: Ying, Qikang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dkjegekgdm8gha3165jse48227